Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Scilex Holding Company logo

Scilex Holding Company

Recent Finacing

Equity

Recent Raise

$5M

Scilex Pharmaceuticals develops Ztildo, a low-dose lidocaine patch for post-herpetic neuralgia using licensed Japanese drug-delivery technology, conducting clinical trials and preparing an FDA new drug application.

California, United States
101-250
Publicly Traded
scilexholding.com

Highlights

Focus Areas

Health Care
Medical
Pharmaceutical

Financials

$5M

Total Raised

1

Funding round


Team

Upgrade to view the team

See the team members at Scilex Holding Company.